Skip to content
Clinical Trials – home
SwedenBack to Sweden

Clinical trials in Malmo – page 21

1 356 clinical trials in Malmo, Sweden across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

SwedenOur site in SwedenKliniska-Provningar.se(opens in a new tab)
Malmo at a glance
1 356
clinical trials
  • Research sites4
Type of trial
Recruitment status
Quick filters

1 356 trials in Malmo

Open in trial search

Study of Trastuzumab Deruxtecan, Rilvegostomig, and Pembrolizumab for Advanced or Recurrent Endometrial Cancer in HER2-Positive Patients

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:AstraZeneca AB

Study of Sacituzumab Tirumotecan and Pembrolizumab for Patients with Advanced or Recurrent Endometrial Cancer

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Merck Sharp & Dohme LLC

Study on the Safety and Effectiveness of Dapagliflozin for Kidney Function in Non-Diabetic Kidney Transplant Patients

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Dapagliflozin
  • Sponsor:Odense University Hospital

Study on Ferric Derisomaltose for Patients with Iron Deficiency and Chronic Heart Failure

Registered drugNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Ferric Derisomaltose
  • Sponsor:Pharmacosmos A/S

Study on the Effects of Psilocybin for Young Adults with Anorexia Nervosa

InvestigationalNo placebo
Countries:SwedenSweden
  • Participants:0–17 years · 18–64 years
  • Sponsor:Region Skane

Study of Sigvotatug Vedotin and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer with High PD-L1 Levels

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Pfizer Inc.

Diabetic foot+1

Recruiting

Study on the Effect of Semaglutide on Healing Foot Ulcers in Patients with Type 2 Diabetes

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Region Hovedstaden

Dementia+7

Recruiting

Study on the Accuracy of Tau PET ([18F]RO6958948) and Vizamyl (Flutemetamol 18F) in Diagnosing Mild Cognitive Symptoms and Risk of Alzheimer's Disease

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Flutemetamol (18F)
  • Sponsor:Region Skane

Psychotic disorder+2

Recruiting

Study on the Effects of GT-002 and Oxazepam for Cognitive Impairment in Schizophrenia Patients

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · Healthy volunteers
  • Substances:GT-002
  • Sponsor:Region Hovedstadens Psykiatriske

Study of DNTH103 Treatment for Adults with Chronic Inflammatory Demyelinating Polyneuropathy: Comparing Effectiveness with Placebo

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:DNTH103
  • Sponsor:Dianthus Therapeutics Inc.

Study on HPV Vaccine and Screening to Reduce HPV Infection and Cervical Cancer in Swedish Women Aged 23-25

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · Healthy volunteers
  • Sponsor:Region Stockholm

Study on the Effects of Different Doses of Adenosine for Patients with Chronic Coronary Syndrome, with and without Heart Failure

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Adenosine
  • Sponsor:Region Skane

Other cities in Sweden

The busiest research cities in the country

All 66 cities in Sweden

Clinical research in Malmo

What the registry says about research in the country

01 Oncology Research

Innovative trials focusing on metastatic prostate cancer treatments and breakthrough therapies for colorectal cancer. Research includes studies of novel drug combinations and targeted therapies for breast cancer patients.

  • Advanced prostate cancer treatments
  • Colorectal cancer interventions
  • Breast cancer therapy optimization
02 Neurodegenerative Disorders

Comprehensive studies on Alzheimer's disease diagnostics and treatment, including innovative research on ALS therapies. Investigations utilize advanced imaging techniques and novel therapeutic approaches.

  • Early Alzheimer's intervention
  • ALS treatment development
  • Cognitive disorder diagnostics
03 Metabolic and Chronic Conditions

Trials examining treatments for obesity and type 2 diabetes, along with innovative approaches to managing chronic kidney disease. Research focuses on biomarker-targeted treatments and lifestyle interventions.

  • Weight management therapies
  • Diabetes treatment optimization
  • Kidney disease interventions
04 Infectious Diseases

Studies evaluating vaccines for respiratory syncytial virus, HPV, and Herpes Zoster. Research aims to prevent viral infections and improve vaccination strategies in various age groups.

  • Viral infection prevention
  • Vaccine effectiveness studies
  • Immunization programs
Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.